Dr. Ram Raj Singh, MD

Dr. Singh practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Singh's NPI, 1013937218, was assigned on July 20, 2006. Dr. Singh graduated from King George's/CSM Medical College in 1983. Dr. Singh holds California license A62830.

Dr. Singh's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Singh's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Singh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Singh's licenses on file in 2 states: California and Ohio.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, joint arthropathy, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Singh treats.

CMS data shows 52 Medicare services from Dr. Singh across 1 procedure code in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $5,619 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 19 patients. 70% of them have arthritis, and 68% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 50, with 79% women.

In 2024, Dr. Singh wrote 196 Medicare Part D claims for 20 patients. 75% of them were for generic drugs. CMS names the drug for 147 of them, across 6 drugs with 11 or more claims each, at $178,740 in total drug cost. In 2023, CMS named 162 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Singh for performance year 2024, reported as part of a group. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth.

Dmand AI links 12 papers to Dr. Singh, published from 2016 to 2023. 2019 was the busiest year, with 3. Dr. Singh's most frequent co-authors are Suzanne Kafaja, MD, Fereidoun G. Abtin, MD and Jihane Nejma Benhammou, BS.

CMS Open Payments shows 2 general payments to Dr. Singh from 2 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $34.

Dr. Singh graduated from King George's/CSM Medical College in 1983.

Dr. Singh is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.